Shire plc and its collaborative partner New River Pharmaceuticals Inc., announce the U.S. Food and Drug Administration has granted marketing approval for VYVANSE (lisdexamfetamine dimesylate, formerly known as NRP104), for the treatment of attention deficit hyperactivity disorder. VYVANSE is a prodrug that is therapeutically inactive until metabolized in the body.
Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) and its collaborative partner New River Pharmaceuticals Inc. (NASDAQ: NRPH) announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for VYVANSE (lisdexamfetamine dimesylate, formerly known as NRP104), for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
Through a grant from the Ohio Board of Regents, three universities will collaborate to provide a unique learning experience to talented high school students and science teachers.
University of Minnesota researchers have discovered a variant of a common blood protein, apolipoprotein C1, in people of American Indian and Mexican ancestry that is linked to elevated body mass index (BMI), obesity and Type 2 diabetes.
Dartmouth/Veterans Affairs researchers have tested whether a primer, which the researchers also wrote, helped people better understand information about health risks and interventions meant to reduce those risks.
The reduction of body iron stores through phlebotomy (blood removal) in patients with peripheral artery disease (PAD) does not appear to decrease the risk of death plus nonfatal cardiovascular events, according to a study published in the February 14 issue of JAMA.
Kenya government has taken all possible steps to confront the Rift valley fever viral infection in Garissa. The death toll continued to rise claiming four more people in just 24 hours. This brings the number of Rift valley fever victims to 74.
On 4_January, 8 new suspected cases of Rift Valley Fever were discovered by MSF teams in the Ijara District in the North-Eastern Province of Kenya. One of the patients died, taking the death toll to at least 67 since the outbreak began on 7_December.
Widespread use of the antiviral Tamiflu to fight pandemic avian flu in humans could actually lead to the development of what public health officials hope to avoid??drug-resistant strains of the virus in wild birds. British researchers at the Centre for Ecology and Hydrology in Oxford have released findings in the January 2007 issue of Environmental Health Perspectives (EHP) that demonstrate how Tamiflu?s persistence in wastewater and river water could affect the waterfowl that drink from those water sources.
Mercury released into the atmosphere is concentrated in aquatic food chains, giving rise to harmful levels in biota in sensitive regions.